1291 related articles for article (PubMed ID: 11176980)
21. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
Blinder KJ; Bradley S; Bressler NM; Bressler SB; Donati G; Hao Y; Ma C; Menchini U; Miller J; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Strong HA; Stur M; Su XY; Virgili G; ;
Am J Ophthalmol; 2003 Sep; 136(3):407-18. PubMed ID: 12967792
[TBL] [Abstract][Full Text] [Related]
22. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
23. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
; ;
Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
[TBL] [Abstract][Full Text] [Related]
25. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Azab M; Benchaboune M; Blinder KJ; Bressler NM; Bressler SB; Gragoudas ES; Fish GE; Hao Y; Haynes L; Lim JI; Menchini U; Miller JW; Mones J; Potter MJ; Reaves A; Rosenfeld PJ; Strong A; Su XY; Slakter JS; Schmidt-Erfurth U; Sorenson JA; ;
Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
[TBL] [Abstract][Full Text] [Related]
26. Verteporfin therapy in age-related macular degeneration (VAM): an open-label multicenter photodynamic therapy study of 4,435 patients.
Bessler NM;
Retina; 2004 Aug; 24(4):512-20. PubMed ID: 15300071
[TBL] [Abstract][Full Text] [Related]
27. Effects of verteporfin therapy on contrast on sensitivity: Results From the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation-TAP report No 4.
Rubin GS; Bressler NM;
Retina; 2002 Oct; 22(5):536-44. PubMed ID: 12441717
[TBL] [Abstract][Full Text] [Related]
28. Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.
Keam SJ; Scott LJ; Curran MP
Drugs; 2003; 63(22):2521-54. PubMed ID: 14609361
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
30. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
[TBL] [Abstract][Full Text] [Related]
31. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
Soubrane G; Harding SP; Wolf S; Weichselberger A
Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
[TBL] [Abstract][Full Text] [Related]
32. Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study.
; Boyer DS; Beer PM; Joffe L; Koester JM; Marx JL; Weisberger A; Yoser SL
Retina; 2007; 27(6):693-700. PubMed ID: 17621177
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis.
Parodi MB; Di Crecchio L; Lanzetta P; Polito A; Bandello F; Ravalico G
Am J Ophthalmol; 2004 Aug; 138(2):263-9. PubMed ID: 15289136
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology.
Ophthalmology; 2000 Dec; 107(12):2314-7. PubMed ID: 11186878
[TBL] [Abstract][Full Text] [Related]
35. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
36. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration.
Frennesson CI; Nilsson SE
Acta Ophthalmol Scand; 2004 Dec; 82(6):645-50. PubMed ID: 15606458
[TBL] [Abstract][Full Text] [Related]
37. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.
Essex RW; Qureshi SH; Cain MS; Harper CA; Guymer RH
Clin Exp Ophthalmol; 2003 Dec; 31(6):476-81. PubMed ID: 14641153
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Mori R; Kelkar A; De Laey JJ
Bull Soc Belge Ophtalmol; 2006; (299):57-64. PubMed ID: 16681088
[TBL] [Abstract][Full Text] [Related]
40. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to management--TAP report No. 6.
Bressler SB; Pieramici DJ; Koester JM; Bressler NM
Arch Ophthalmol; 2004 Mar; 122(3):325-9. PubMed ID: 15006843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]